Literature DB >> 24998555

Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).

Jing-Luan Wang1, Da-Wei Wu, Zhao-Zhong Cheng, Wei-Zhong Han, Sheng-Wei Xu, Ni-Na Sun.   

Abstract

OBJECTIVE: This study evaluated the expression level of high mobility group box-B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC) inmorder to reveal any relation with development and prognosis.
METHODS: NSCLC and normal tissues were selected from 30 patients at age of 30- 73, and used for RT-PCR and Western blot analyses of HMGB-1. A total of 100 paraffin embedded NSCLC tissues were also isolated from patients through surgical resection, and used for detection of HMGB-1 by immunohistochemistry. In addition, 50 samples were also applied for MMP-9 detection, and 30 normal tissues were considered as controls. Correlation analysis of HMGB-1 and MMP-9 was carried out by Pearsons correlation coefficient.
RESULTS: The average expression level of HMGB-1 in NSCLC patients was significantly higher than in normal lung tissues. In addition, patients in III-IV period exhibit significantly higher positive rate of HMGB- 1 when compared with I-II period cases. Furthermore, a positive correlation with HMGB-1 was found in the expression of MPP-9.
CONCLUSION: HMGB-1 was highly expressed in NSCLC, which may become a prognostic and predictive marker for NSCLC. Besides, MPP-9 was positively correlated with HMGB-1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24998555     DOI: 10.7314/apjcp.2014.15.12.4865

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

1.  High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer.

Authors:  Feng Wei; Fan Yang; Xiangli Jiang; Wenwen Yu; Xiubao Ren
Journal:  Tumour Biol       Date:  2015-06-26

2.  Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.

Authors:  José Manuel Ruiz-Morales; Rita Dorantes-Heredia; Oscar Arrieta; Norberto C Chávez-Tapia; Daniel Motola-Kuba
Journal:  Tumour Biol       Date:  2014-12-27

Review 3.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

4.  Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review.

Authors:  Quansong Xia; Juan Xu; Huoying Chen; Yanzhang Gao; Feili Gong; Liya Hu; Li Yang
Journal:  Onco Targets Ther       Date:  2016-06-29       Impact factor: 4.147

Review 5.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

6.  New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer.

Authors:  Maiko Niki; Takashi Yokoi; Takayasu Kurata; Shosaku Nomura
Journal:  Lung Cancer (Auckl)       Date:  2017-08-03

7.  Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma.

Authors:  Hui Cheng; Weiqi Wang; Yanling Zhang; Bei Zhang; Jie Cheng; Peng Teng; Xin Tang
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

8.  The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.

Authors:  Liu Xu; Wang Lina; Yin Xuejun
Journal:  Open Med (Wars)       Date:  2016-03-26

9.  Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.

Authors:  Shibo Ying; Zhaoqiang Jiang; Xianglei He; Min Yu; Riping Chen; Junqiang Chen; Guoqing Ru; Yuan Chen; Wanyuan Chen; Lijin Zhu; Tao Li; Yixiao Zhang; Xinnian Guo; Xianhong Yin; Xing Zhang; Jianlin Lou
Journal:  Dis Markers       Date:  2017-03-01       Impact factor: 3.434

10.  High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-κB-Dependent Manner.

Authors:  Xiaojin Wu; Weitao Wang; Yuanyuan Chen; Xiangqun Liu; Jindong Wang; Xiaobin Qin; Dawei Yuan; Tao Yu; Guangxia Chen; Yanyan Mi; Jie Mou; Jinpeng Cui; Ankang Hu; Yunxiang E; Dongsheng Pei
Journal:  Biomed Res Int       Date:  2018-04-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.